N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability

被引:35
|
作者
Zou, Libin [1 ]
Chen, Wenbin [1 ]
Zhou, Xumin [1 ]
Yang, Taowei [1 ]
Luo, Junqi [1 ]
Long, Zining [1 ]
Wu, Jun [1 ]
Lv, Daojun [2 ]
Mao, Xiangming [1 ]
Cen, Shengren [1 ]
机构
[1] Southern Med Univ, Zhujiang Hosp, Dept Urol, Guangzhou, Peoples R China
[2] Guangzhou Med Univ, Dept Urol, Affiliated Hosp 3, Guangzhou, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
METHYLATION; CHANNEL;
D O I
10.1038/s41420-022-01003-7
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The fat mass and obesity-associated protein (FTO) is an N6-Methyladenosine (m6A) demethylase, which has been revealed to play critical roles in tumorigenesis. However, its role in the development and progression of prostate cancer (PCa) remains poorly understood. Here, we aimed to investigate the function and clinical relevance of FTO in PCa. Our results demonstrated that FTO was notably downregulated in PCa tissues compared with the paired normal tissues. In addition, the decreased expression of FTO was correlated with poor prognosis of PCa. Functional experiments showed that depletion of FTO promoted the proliferation and metastasis of PCa both in vitro and in vivo. Conversely, ectopic expression of FTO exhibited the opposite effects. Combined with RNA-sequencing, MeRIP-RT-qPCR, and mRNA stability assays indicated chloride intracellular channel 4(CLIC4) was a functional target of FTO-mediated m6A modification. FTO depletion significantly increased the m6A level of CLIC4 mRNA and then reduced the mRNA stability. In conclusion, our findings suggest that FTO suppresses PCa proliferation and metastasis through reducing the degradation of CLIC4 mRNA in an m6A dependent manner. FTO may be used as a promising novel therapeutic target and prognostic evaluation biomarker for PCa.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability
    Libin Zou
    Wenbin Chen
    Xumin Zhou
    Taowei Yang
    Junqi Luo
    Zining Long
    Jun Wu
    Daojun Lv
    Xiangming Mao
    Shengren Cen
    Cell Death Discovery, 8
  • [2] Roles of N6-Methyladenosine Demethylase FTO in Malignant Tumors Progression
    Zheng, Qing-Kang
    Ma, Chao
    Ullah, Irfan
    Hu, Kang
    Ma, Rui-Jie
    Zhang, Nan
    Sun, Zhi-Gang
    ONCOTARGETS AND THERAPY, 2021, 14 : 4837 - 4846
  • [3] Nitric oxide inhibits FTO demethylase activity to regulate N6-methyladenosine mRNA methylation
    Kuschman, Hannah Petraitis
    Palczewski, Marianne B.
    Hoffman, Brian
    Menhart, Mary
    Wang, Xiaowei
    Glynn, Sharon
    Islam, Abul B. M. M. K.
    Benevolenskaya, Elizaveta V.
    Thomas, Douglas D.
    REDOX BIOLOGY, 2023, 67
  • [4] Nitric oxide inhibits FTO demethylase activity to regulate N6-methyladenosine mRNA methylation
    Thomas, Douglas
    FREE RADICAL BIOLOGY AND MEDICINE, 2023, 208 : S143 - S143
  • [5] Regulatory roles of the N6-methyladenosine demethylase FTO in cardiac remodeling
    Annamalai, K.
    Buchholz, E.
    Castro, R.
    Panyam, N.
    Fischer, A.
    Toischer, K.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [6] A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities
    Xie, Guoyou
    Wu, Xu-Nian
    Ling, Yuyi
    Rui, Yalan
    Wu, Deyan
    Zhou, Jiawang
    Li, Jiexin
    Lin, Shuibin
    Peng, Qin
    Li, Zigang
    Wang, Hongsheng
    Luo, Hai-Bin
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (02) : 853 - 866
  • [7] N6-Methyladenosine Demethylase FTO Controls Macrophage Homeostasis in Diabetic Vasculopathy
    Feng, Siguo
    Zhang, Qiuyang
    Liu, Qing
    Huang, Chang
    Zhang, Huiying
    Wang, Fengsheng
    Zhu, Yue
    Jian, Qizhi
    Chen, Xue
    Jiang, Qin
    Yan, Biao
    DIABETES, 2025, 74 (01)
  • [8] N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway
    Jing, Yuan-Xue
    Li, Hong-Xing
    Yue, Feng
    Li, Yan-Mei
    Yu, Xiao
    He, Jia-Jing
    Zhang, Xue-Hong
    GYNECOLOGICAL ENDOCRINOLOGY, 2023, 39 (01)
  • [9] Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor
    Chen, Baoen
    Ye, Fei
    Yu, Lu
    Jia, Guifang
    Huang, Xiaotian
    Zhang, Xueju
    Peng, Shuying
    Chen, Kai
    Wang, Meining
    Gong, Shouze
    Zhang, Ruihan
    Yin, Jinya
    Li, Haiyan
    Yang, Yiming
    Liu, Hong
    Zhang, Jiwen
    Zhang, Haiyan
    Zhang, Ao
    Jiang, Hualiang
    Luo, Cheng
    Yang, Cai-Guang
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (43) : 17963 - 17971
  • [10] RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
    Yi Niu
    Ziyou Lin
    Arabella Wan
    Honglei Chen
    Heng Liang
    Lei Sun
    Yuan Wang
    Xi Li
    Xiao-feng Xiong
    Bo Wei
    Xiaobin Wu
    Guohui Wan
    Molecular Cancer, 18